Compared evolution of plasma fibronectin and angiotensin-converting enzyme levels in septic ARDS
- PMID: 2981657
- DOI: 10.1378/chest.87.2.191
Compared evolution of plasma fibronectin and angiotensin-converting enzyme levels in septic ARDS
Abstract
Serum angiotensin converting enzyme (serum ACE) levels and plasma fibronectin levels were measured daily in 46 septic patients during a ten day period. Thirty-eight patients developed ARDS; 28 survived (group 1), ten died (group 2), eight patients had no features of ARDS and survived (group 3). Sequential measurements of ACE and fibronectin levels were compared and plotted against indexes of respiratory impairment: PaO2 max Qs/Qt, static compliance and VD/VA ratio. These indexes were taken as criteria of weaning from controlled ventilation. During ARDS (groups 1 and 2), serum ACE levels decreased and were closely correlated with the severity of lung injury. Persistently decreased levels after eight days were consistent with continuing injury or lack of endothelial repair. On the other hand, plasma fibronectin levels increased throughout the study in survivors (group 1 and 3) and decreased in the group with fatal ARDS only (group 2). These results indicate that serum ACE levels might be a good index of endothelial injury and repair during ARDS and fibronectin a better index for evolution of sepsis and vital prognosis.
Similar articles
-
[Angiotensin converting enzyme in the adult respiratory distress syndrome].Schweiz Med Wochenschr. 1985 Feb 9;115(6):202-5. Schweiz Med Wochenschr. 1985. PMID: 2983416 German.
-
Angiotensin-converting enzyme in human adult respiratory distress syndrome.Chest. 1983 Apr;83(4):593-7. doi: 10.1378/chest.83.4.593. Chest. 1983. PMID: 6299654
-
Decreased serum angiotensin converting enzyme in adult respiratory distress syndrome associated with sepsis: a preliminary report.Crit Care Med. 1981 Sep;9(9):651-4. doi: 10.1097/00003246-198109000-00008. Crit Care Med. 1981. PMID: 6268354
-
Endothelial function studies in pulmonary vascular disease: determination of angiotensin converting enzyme activity in humans (review).Int J Mol Med. 2002 Mar;9(3):317-25. Int J Mol Med. 2002. Retraction in: Int J Mol Med. 2002 Nov;10(5):665. doi: 10.3892/ijmm.10.5.665. PMID: 11836639 Retracted. Review.
-
[Angiotensin converting enzyme as an indicator of lung damage in septic shock].Przegl Lek. 1988;45(12):840-3. Przegl Lek. 1988. PMID: 2854646 Review. Polish. No abstract available.
Cited by
-
Angiotensin-converting enzyme insertion/deletion polymorphism is associated with severe hypoxemia in pediatric ARDS.Intensive Care Med. 2012 Jan;38(1):113-9. doi: 10.1007/s00134-011-2381-3. Epub 2011 Oct 18. Intensive Care Med. 2012. PMID: 22005825
-
Plasma fibronectin and the critically ill.Intensive Care Med. 1986;12(5):337-9. doi: 10.1007/BF00292922. Intensive Care Med. 1986. PMID: 3771913 No abstract available.
-
Soluble angiotensin-converting enzyme 2 is transiently elevated in COVID-19 and correlates with specific inflammatory and endothelial markers.J Med Virol. 2021 Oct;93(10):5908-5916. doi: 10.1002/jmv.27144. Epub 2021 Jul 6. J Med Virol. 2021. PMID: 34138483 Free PMC article.
-
Combination of Angiotensin (1-7) Agonists and Convalescent Plasma as a New Strategy to Overcome Angiotensin Converting Enzyme 2 (ACE2) Inhibition for the Treatment of COVID-19.Front Med (Lausanne). 2021 Mar 18;8:620990. doi: 10.3389/fmed.2021.620990. eCollection 2021. Front Med (Lausanne). 2021. PMID: 33816521 Free PMC article. Review.
-
The Angiotensin Converting Enzyme Insertion/Deletion polymorphism is not associated with an increased risk of death or bronchopulmonary dysplasia in ventilated very low birth weight infants.BMC Pediatr. 2004 Dec 20;4(1):26. doi: 10.1186/1471-2431-4-26. BMC Pediatr. 2004. PMID: 15610555 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous